Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Better Therapeutics, Inc. (BTTX)
OTHER OTC:BTTX
Holding BTTX?
Track your performance easily
BTTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.27
Previous Close$0.01
Volume1.59K
Average Volume (3M)N/A
Market Cap
$5.43K
Enterprise Value$7.71M
Total Cash (Recent Filing)$6.60M
Total Debt (Recent Filing)$14.31M
Price to Earnings (P/E)―
Beta204.66
Next Earnings
Nov 11, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.16
Shares Outstanding54,520,000
10 Day Avg. Volume26,145
30 Day Avg. VolumeN/A
Standard Deviation0.36
R-Squared0.06
Alpha-0.12
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.41
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Better Therapeutics, Inc. News
PremiumCompany Announcements
Better Therapeutics Overhaul and Nasdaq Delisting
PremiumCompany Announcements
Better Therapeutics Issues Investor Presentation with Cautions
PremiumCompany Announcements
Better Therapeutics CEO Discusses Future on Bloomberg TVOwnership Overview
41.69% Insiders
0.13% Other Institutional Investors
58.18% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BTTX FAQ
What was Better Therapeutics, Inc.’s price range in the past 12 months?
Better Therapeutics, Inc. lowest stock price was <$0.01 and its highest was $0.27 in the past 12 months.
What is Better Therapeutics, Inc.’s market cap?
Currently, no data Available
When is Better Therapeutics, Inc.’s upcoming earnings report date?
Better Therapeutics, Inc.’s upcoming earnings report date is Nov 11, 2024 which is 12 days ago.
How were Better Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Better Therapeutics, Inc. overvalued?
According to Wall Street analysts Better Therapeutics, Inc.’s price is currently Overvalued.
Does Better Therapeutics, Inc. pay dividends?
Better Therapeutics, Inc. does not currently pay dividends.
What is Better Therapeutics, Inc.’s EPS estimate?
Better Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Better Therapeutics, Inc. have?
Better Therapeutics, Inc. has 54,352,497 shares outstanding.
What happened to Better Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Better Therapeutics, Inc.?
Among the largest hedge funds holding Better Therapeutics, Inc.’s share is Farallon Capital Management, L.L.C.. It holds Better Therapeutics, Inc.’s shares valued at N/A.
---
Better Therapeutics, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Better Therapeutics, Inc.
Mountain Crest Acquisition Corp II is a blank check company.
---
BTTX Earnings Call
Q3 2023
0:00 / 0:00
---
BTTX Stock 12 Month Forecast
Average Price Target
―Aldeyra Therapeutics
―
Bioxcel Therapeutics
―
Anavex Life Sciences
―
Krystal Biotech
―
Best Analysts Covering BTTX
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-77.60%
reiterated a buy rating 12 months ago
Copying Thomas Flaten's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -77.60% per trade.
---